ABVC BioPharma, Inc. Deferred Income Tax Assets, Net
ABVC BioPharma, Inc. (ABVC) had Deferred Income Tax Assets, Net of $34.26 thousand as of 2023-09-30, per its 10-Q filed 2023-11-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2024-03-13
- 2023-09-30: Deferred Income Tax Assets, Net $34.26K.
- 2023-06-30: Deferred Income Tax Assets, Net $35.47K.
- 2023-03-31: Deferred Income Tax Assets, Net $118.19K.
- 2022-12-31: Deferred Income Tax Assets, Net $117.11K.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2023-09-30 | $34.26K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $35.47K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $118.19K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $117.11K 10-K · filed 2024-03-13 |
| 2022-09-30 | $1.01M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.08M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.04M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $981.91K 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.99M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.91M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.82M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.79M 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.65M 10-Q · filed 2020-11-17 |
| 2020-06-30 | $1.58M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.49M 10-Q · filed 2020-06-29 |
| 2019-12-31 | $1.46M 10-K · filed 2021-03-16 |